Peter Brent Sampson,Yong Liu,Sze-Wan Li,Bryan T. Forrest,Heinz W. Pauls,Louise G. Edwards,Miklos Feher,Narendra Kumar B. Patel,Radoslaw Laufer,Guohua Pan
申请号：
US14823057
公开号：
US20160045511A1
申请日:
2015.08.11
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof:Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.
